Prevention of intrahepatic distant recurrence by transcatheter arterial infusion chemotherapy with platinum agents for stage I/II hepatocellular carcinoma
BACKGROUND: The effectiveness of additional chemotherapy in preventing intrahepatic distant tumor recurrence of hepatocellular carcinoma (HCC) has not been fully established. The authors compared the efficacy of 2 platinum‐based chemotherapeutic agents in combination with radical local treatment for...
Saved in:
Published in: | Cancer Vol. 117; no. 17; pp. 4018 - 4025 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01-09-2011
Wiley Subscription Services, Inc |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | BACKGROUND:
The effectiveness of additional chemotherapy in preventing intrahepatic distant tumor recurrence of hepatocellular carcinoma (HCC) has not been fully established. The authors compared the efficacy of 2 platinum‐based chemotherapeutic agents in combination with radical local treatment for preventing intrahepatic distant recurrence (IDR).
METHODS:
Seventy‐eight patients with stage I/II HCC aged 45 to 85 years underwent transcatheter arterial chemoembolization and/or radiofrequency ablation after they received hepatic arterial infusion (HAI) of platinum compounds. The HAI consisted of cis‐diammine(1,1‐cyclobutanedicarboxylato)platinum(II) (carboplatin) in 25 patients and cis‐diamminedichloroplatinum (II) (cisplatin) in 53 patients. Multivariate analysis was used to identify independent factors that were associated with IDR.
RESULTS:
Cumulative IDR rates at 1 year, 2 years, and 3 years were 21.7%, 52.2% and 75.7%, respectively, in the carboplatin group and 8.1%, 22.7%, and 36.9%, respectively, in the cisplatin group. The cisplatin group had a significantly lower IDR rate compared with the carboplatin group. The selection of a platinum agent was 1 of the independent factors for IDR in a multivariate Cox proportional hazards model.
CONCLUSIONS:
HAI chemotherapy with cisplatin before radical local treatment was effective in patients with HCC. The authors concluded that radical local treatment with concurrent HAI using cisplatin may contribute to a longer progression‐free period, which could be predicted with intrahepatic imaging in patients with stage I/II HCC. Cancer 2011;. © 2011 American Cancer Society.
The authors compared the efficacy of 2 platinum‐based chemotherapeutic agents in combination with radical local treatment for preventing intrahepatic distant recurrence in patients with hepatocellular carcinoma (HCC). Hepatic arterial infusion (HAI) chemotherapy with cis‐diamminedichloroplatinum (II) (cisplatin) before radical local treatment was effective in patients with HCC. The results indicated that radical local treatment with concurrent HAI using cisplatin may contribute to a longer progression‐free period, which could be predicted with intrahepatic imaging in patients with stage I/II HCC. |
---|---|
Bibliography: | Fax: (011) 81‐25‐233‐8880 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0008-543X 1097-0142 |
DOI: | 10.1002/cncr.25989 |